A phase I/II study of the safety and efficacy of [177Lu]Lu-satoreotide tetraxetan in advanced somatostatin receptor-positive neuroendocrine tumours.

Autor: Wild, Damian1 (AUTHOR) damian.wild@usb.ch, Grønbæk, Henning2 (AUTHOR), Navalkissoor, Shaunak3 (AUTHOR), Haug, Alexander4 (AUTHOR), Nicolas, Guillaume P.1 (AUTHOR), Pais, Ben5,6 (AUTHOR), Ansquer, Catherine7 (AUTHOR), Beauregard, Jean-Mathieu8 (AUTHOR), McEwan, Alexander6 (AUTHOR), Lassmann, Michael9 (AUTHOR), Pennestri, Daniele10 (AUTHOR), Volteau, Magali11 (AUTHOR), Lenzo, Nat P.12,13 (AUTHOR), Hicks, Rodney J.14,15 (AUTHOR)
Zdroj: European Journal of Nuclear Medicine & Molecular Imaging. Dec2023, Vol. 51 Issue 1, p183-195. 13p.
Databáze: Academic Search Ultimate
Nepřihlášeným uživatelům se plný text nezobrazuje